第3天时差成像选择与第5天常规形态学选择的单胚胎移植:一项随机、开放标签、非劣效性试验
这项单中心随机开放标签非劣效性试验纳入600名中国女性,比较第3天时差成像分级分类模型选择单胚胎移植与第5天常规形态学选择单囊胚移植的持续妊娠率。符合方案集分析显示第3天组持续妊娠率显著低于第5天组(59.4% vs 68.4%,差值-9.0%,95%CI -17.1%至-0.7%,P=0.03)。作者认为第3天时差成像选择方案的持续妊娠率虽显著较低,但在接受IVF的女性中似乎临床可接受。
要点
- 符合方案集分析中,第3天时差成像组持续妊娠率59.4%(155/261)显著低于第5天常规形态学组68.4%(175/256),差值-9.0%(95%CI -17.1%至-0.7%,P=0.03)。
- 改良意向治疗分析中两组持续妊娠率差异边缘显著:第3天组56.6% vs 第5天组64.1%,差值-7.5%(95%CI -15.4%至0.4%,P=0.06)。
- 符合方案集分析中第3天组种植率显著低于第5天组(64.4% vs 77.0%,P=0.002),两组早期流产率无显著差异。
核心结论
- 第3天时差成像分级分类模型选择的单胚胎移植持续妊娠率显著低于第5天常规形态学选择的单囊胚移植,但作者认为在接受IVF的女性中似乎临床可接受。
研究设计与样本
- 单中心、随机、开放标签、活性对照、非劣效性研究,2015年10月至2017年4月纳入600名女性,1:1随机分为第3天时差成像分级分类模型选择单胚胎移植组(D3+TL)和第5天常规形态学选择单囊胚移植组(D5+CM)。
主要发现
- 符合方案集(D3+TL=261,D5+CM=256)中,D3组持续妊娠率59.4%(155/261)显著低于D5组68.4%(175/256),差值-9.0%(95%CI -17.1%至-0.7%,P=0.03)。
- 改良意向治疗集(D3+TL=290,D5+CM=295)中,D3组持续妊娠率56.6% vs D5组64.1%,差值-7.5%(95%CI -15.4%至0.4%,P=0.06),差异边缘显著。
- 符合方案集分析中,D3+TL组种植率64.4%显著低于D5+CM组77.0%(P=0.002),两组早期流产率无显著差异。
临床怎么用
- 作者认为第3天时差成像分级分类模型选择的单胚胎移植持续妊娠率虽显著低于第5天常规形态学选择,但在接受IVF的女性中似乎临床可接受。
局限性
- 研究缺乏第3天单胚胎移植时差成像选择与常规形态学选择的直接比较。
- 研究统计学把握度不足以检测非劣效性。
- 受试者入选标准偏向IVF预后良好的女性,削弱了结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does single cleavage-stage (Day 3) embryo transfer using a time-lapse (TL) hierarchical classification model achieve comparable ongoing pregnancy rates (OPR) to single blastocyst (Day 5) transfer by conventional morphological (CM) selection? SUMMARY ANSWER: Day 3 single embryo transfer (SET) with a hierarchical classification model had a significantly lower OPR compared with Day 5 SET with CM selection. WHAT IS KNOWN ALREADY: Cleavage-stage SET is an alternative to blastocyst SET. Time-lapse imaging assists better embryo selection, based on studies of pregnancy outcomes when adding time-lapse imaging to CM selection at the cleavage or blastocyst stage. STUDY DESIGN, SIZE, DURATION: This single-centre, randomized, open-label, active-controlled, non-inferiority study included 600 women between October 2015 and April 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: Eligible patients were Chinese females, aged ≤36 years, who were undergoing their first or second fresh IVF cycle using their own oocytes, and who had FSH levels ≤12 IU/mL on Day 3 of the cycle and 10 or more oocytes retrieved. Patients who had underlying uterine conditions, oocyte donation, recurrent pregnancy loss, abnormal oocytes or <6 normally fertilized embryos (2PN) were excluded from the study participation. Patients were randomized 1:1 to either the cleavage-stage SET with a time-lapse hierarchical classification model for selection (D3 + TL) or blastocyst SET with CM selection (D5 + CM). All normally fertilized zygotes were cultured in Primo Vision. The study was conducted at a tertiary IVF centre (CITIC-Xiangya) and OPR was the primary outcome. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 600 patients were randomized to the two groups, among which 585 (D3 + TL = 290, D5 + CM = 295) were included in the Modified-intention-to-treat (mITT) population and 517 (D3 + TL = 261, D5 + CM = 256) were included in the PP population. In the per protocol (PP) population, OPR was significantly lower in the D3 group (59.4%, 155/261) than in the D5 group (68.4%, 175/256) (difference: -9.0%, 95% CI: -17.1%, -0.7%, P = 0.03). Analysis in mITT population showed a marginally significant difference in the OPR between the D3 + TL and D5 + CM groups (56.6 versus 64.1%, difference: -7.5%, 95% CI: -15.4%, 0.4%, P = 0.06). The D3 + TL group resulted in a markedly lower implantation rate than the D5 + CM group (64.4 versus 77.0%; P = 0.002) in the PP analysis, however, the early miscarriage rate did not significantly differ between the two groups. LIMITATIONS, REASONS FOR CAUTION: The study lacked a direct comparison between time-lapse and CM selections at cleavage-stage SET and was statistically underpowered to detect non-inferiority. The subject's eligibility criteria favouring women with a good prognosis for IVF weakened the generalizability of the results. WIDER IMPLICATIONS OF THE FINDINGS: The OPR from Day 3 cleavage-stage SET using hierarchical classification time-lapse selection was significantly lower compared with that from Day 5 blastocyst SET using conventional morphology, yet it appeared to be clinically acceptable in women underwent IVF. STUDY FUNDING/COMPETING INTEREST(S): This study is supported by grants from Ferring Pharmaceuticals and the Program for New Century Excellent Talents in University, China. TRIAL REGISTRATION NUMBER: ChiCTR-ICR-15006600. TRIAL REGISTRATION DATE: 16 June 2015. DATE OF FIRST PATIENT’S ENROLMENT: 1 October 2015.
引用
- Yang L, Cai S, Zhang S, et al. Single embryo transfer by Day 3 time-lapse selection versus Day 5 conventional morphological selection: a randomized, open-label, non-inferiority trial. Hum Reprod. 2018. PMID: 29546361. doi:10.1093/humrep/dey047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。